Five‐year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low‐exposure cyclosporine versus standard therapy

HERAKLES was a 1‐year randomized, multicenter trial. Patients were randomized at 3 months after kidney transplantation to remain on cyclosporine‐based therapy, switch to everolimus without a calcineurin inhibitor (CNI), or switch to everolimus with low‐exposure cyclosporine. Overall, 417 of 497 (83....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of transplantation 2018-12, Vol.18 (12), p.2965-2976
Hauptverfasser: Sommerer, Claudia, Duerr, Michael, Witzke, Oliver, Lehner, Frank, Arns, Wolfgang, Kliem, Volker, Ackermann, Daniel, Guba, Markus, Jacobi, Johannes, Hauser, Ingeborg A., Stahl, Rolf, Reinke, Petra, Rath, Thomas, Veit, Justyna, Mehrabi, Arianeb, Porstner, Martina, Budde, Klemens, Mühlfeld, Anja, Babel, Nina, Schäffner, Elke, Hugo, Christian, Pressmar, Katharina, Pietruck, Frank, Kribben, Andreas, Asbe‐Vollkopf, Aida, Pisarski, Przemyslaw, Drognitz, Oliver, Thaiss, Friedrich, Klempnauer, Jürgen, Weithofer, Peter, Zeier, Martin, Huppertz, Andrea, Hackenberg, Ruth, Nitschke, Martin, Jauch, Karl‐Günter, Andrassy, Joachim, Stangl, Manfred, Thorban, Stefan, Banas, Bernhard, Frey, Felix, Vogt, Bruno
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!